MBC - Marketing, Branding & Creative - Global Launch Campaign for Flexadin Advanced

ISSUE

The medicinal value of Glucosamine and Chondroitin in osteoarthritis (OA), is accepted by pet owners and tolerated by vets, despite a lack of objective evidence. To challenge the conventional way of doing things, Vetoquinol developed New Flexadin Advanced and required a global launch campaign strategy and creative concept that would ensure both stand out and success to change the default prescribing habits of vets.

IDEA

New Flexadin Advanced’s unique combination of a proven Chondroprotective agent (UC-II) and Phyto-therapy (Boswellia Serrata) makes it a more compelling choice than the default options available. Our concept sought to capture this idea of uniqueness and the synergy between these two ingredients by drawing a parallel with the special relationship that pet owners have with their pets. Targeted at vets, we created a series of visual executions that contained energy and movement – showing that with New Flexadin Advanced – pets and their owners can do more together.

IMPACT

As the lead creative agency, we developed a global launch campaign for this new product and delivered a toolkit of guidelines and assets to allow the campaign to be locally executed across 12 countries and 8 languages.

“The international campaign produced excellent results – countries which have either the old or the new formulation of Flexadin Advanced saw growth in sales turnover for the year to November 2019 of over 40%, and the countries that launched with the new Boswellia formulation also saw significant year-on-year growth.”

Isabelle Lê Quan DVM, International Range Marketing Manager.

View another case study

ROYAL CANIN

NCAM

Back To Portfolio

FLEXADIN

ISSUE

IDEA

IMPACT

View another case study